Citations (14)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Aurélie Pager, Anne Combedazou, Karen Guerrero, Tzvetelina Tzvetkova-Chevolleau, Didier Morel, Cécile Frolet & Stanislav Glezer. (2020) User experience for manual injection of 2 mL viscous solutions is enhanced by a new prefillable syringe with a staked 8 mm ultra-thin wall needle. Expert Opinion on Drug Delivery 17:10, pages 1485-1498.
Read now
Read now
Masaaki Niino. (2011) Therapeutic application of monoclonal antibodies in multiple sclerosis: focus on alemtuzumab. Degenerative Neurological and Neuromuscular Disease 1, pages 33-42.
Read now
Read now
Articles from other publishers (12)
Nehal E. Elsadek, Eri Hondo, Taro Shimizu, Haruka Takata, Amr S. Abu Lila, Sherif E. Emam, Hidenori Ando, Yu Ishima & Tatsuhiro Ishida. (2020) Impact of Pre-Existing or Induced Anti-PEG IgM on the Pharmacokinetics of Peginterferon Alfa-2a (Pegasys) in Mice. Molecular Pharmaceutics 17:8, pages 2964-2970.
Crossref
Crossref
Babina Gosangi, Matthew Davids, Bhanusupriya Somarouthu, Francesco Alessandrino, Angela Giardino, Nikhil Ramaiya & Katherine Krajewski. (2018) Review of targeted therapy in chronic lymphocytic leukemia: what a radiologist needs to know about CT interpretation. Cancer Imaging 18:1.
Crossref
Crossref
Liang Zhang, Tejas Navaratna & Greg M. Thurber. (2016) A Helix-Stabilizing Linker Improves Subcutaneous Bioavailability of a Helical Peptide Independent of Linker Lipophilicity. Bioconjugate Chemistry 27:7, pages 1663-1672.
Crossref
Crossref
Sarfaraz Niazi. 2015. Biosimilars and Interchangeable Biologics. Biosimilars and Interchangeable Biologics
23
66
.
Manman Wei, Xiang Wang, Zilan Song, Mingkun Jiao, Jian Ding, Ling-Hua Meng & Ao Zhang. (2015) Targeting PI3Kδ: Emerging Therapy for Chronic Lymphocytic Leukemia and Beyond. Medicinal Research Reviews 35:4, pages 720-752.
Crossref
Crossref
Wolfgang F. Richter & Björn Jacobsen. (2014) Subcutaneous Absorption of Biotherapeutics: Knowns and Unknowns. Drug Metabolism and Disposition 42:11, pages 1881-1889.
Crossref
Crossref
Nagaraju Anreddy, Pranav Gupta, Rishil Kathawala, Atish Patel, John Wurpel & Zhe-Sheng Chen. (2014) Tyrosine Kinase Inhibitors as Reversal Agents for ABC Transporter Mediated Drug Resistance. Molecules 19:9, pages 13848-13877.
Crossref
Crossref
Eduardo Nobile-Orazio & Francesca Gallia. (2013) Multifocal Motor Neuropathy: Current Therapies and Novel Strategies. Drugs 73:5, pages 397-406.
Crossref
Crossref
Michael G ToveyChristophe Lallemand. (2012) Improved analytical methods for the detection and quantification of neutralizing antibodies to biopharmaceuticals. Bioanalysis 4:17, pages 2179-2190.
Crossref
Crossref
Annette Czernik, Michael Camilleri, Mark R. Pittelkow & Sergei A. Grando. (2011) Paraneoplastic autoimmune multiorgan syndrome: 20 years after. International Journal of Dermatology 50:8, pages 905-914.
Crossref
Crossref
Eric T. Boder & Wei Jiang. (2011) Engineering Antibodies for Cancer Therapy. Annual Review of Chemical and Biomolecular Engineering 2:1, pages 53-75.
Crossref
Crossref
Michael G. Tovey & Christophe Lallemand. (2011) Immunogenicity and other problems associated with the use of biopharmaceuticals. Therapeutic Advances in Drug Safety 2:3, pages 113-128.
Crossref
Crossref